By Editor , 25 September 2026
Hoonr Lands Three Fortune 500 Clients, Adds Global Freelance Compliance Tool

Alpharetta – September 25, 2026 -- Hoonr, an AI-first Workforce Orchestration platform, has secured three Fortune 500 enterprise clients within five months of its April 2026 launch, spanning life sciences, professional services and engineering sectors.

Three Fortune 500 firms select Hoonr's AI sourcing and analytics tools

The wins mark early validation for the platform's Direct Sourcing and Workforce Orchestration capabilities, which target enterprises managing fragmented technology stacks across their talent operations.

By Editor , 25 September 2026
Burjeel Holdings Convenes UNGA Roundtable on $1 Trillion Women's Health Gap

New York – September 25, 2026 -- Global healthcare, investment, philanthropy and government leaders convened at a roundtable on the sidelines of the 81st United Nations General Assembly to address a women's health gap that the World Economic Forum projects could exceed $1 trillion annually by 2040 if unaddressed. The session, titled "The $1 Trillion Case for Women's Health," was convened by Burjeel Holdings, a super-specialty healthcare provider operating across the UAE, Oman and Saudi Arabia.

By Editor , 25 September 2026
J&J's CARVYKTI Shows 50% Five-Year Remission Rate in Early-Line Myeloma

Raritan, N.J. – September 25, 2026 -- Half of patients with early-line relapsed or refractory multiple myeloma treated with a single infusion of Johnson & Johnson's CARVYKTI® (ciltacabtagene autoleucel) remained alive and progression-free for at least five years without maintenance therapy, according to new long-term data from the Phase 2 CARTITUDE-2 study.

By Editor , 25 September 2026
ICAC, UNODC Train 35 Law Enforcers From 19 Jurisdictions on Illicit Wealth

Hong Kong – September 25, 2026 -- The Independent Commission Against Corruption (ICAC) of Hong Kong and the United Nations Office on Drugs and Crime (UNODC) trained 35 law enforcement officials from 19 jurisdictions in a 10-day programme running September 7 to 16, targeting the investigation of illicit enrichment by public officials.

By Editor , 25 September 2026
REGENXBIO: 60% of Sura-Vec Patients Show DRSS Gains at 3 Years

Rockville, Md. – September 24, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) reported that 60% of Dose Level 3 participants with three-year follow-up data in its Phase II ALTITUDE study achieved a greater-than-2-step improvement on the Diabetic Retinopathy Severity Scale (DRSS) after a single in-office treatment with investigational gene therapy sura-vec, with no vision-threatening events recorded among responders.

By Editor , 25 September 2026
The Starr Conspiracy Debuts Free AI Battle Card Builder for B2B Tech

Fort Worth, Texas – September 24, 2026 -- The Starr Conspiracy has launched Battle Card Builder, a free tool that generates competitive intelligence on a company and three named competitors in about four minutes, giving B2B tech sales and marketing teams instant access to pricing data, objection handlers and deal strategy without a login or credit card.